Anti-Muscarinic Drugs: reimbursement
With the exception of Oxybutynin, in Italy, drugs for hyper active bladders are not refundable. The Italian Agency for Drugs, is currently reviewing this issue: doctors and patient all hope that this may change and that this class of drugs, considered effective and well tolerated throughout other European countries, will become refundable.
With the exception of Oxybutynin, in Italy, drugs for hyper active bladders are not refundable. The Italian Agency for Drugs, is currently reviewing this issue: doctors and patient all hope that this may change and that this class of drugs, considered effective and well tolerated throughout other European countries, will become refundable.
28th Annual EAU Congress
The progression of benign prostatic disease
it
Prof. Vincenzo Mirone
When Open Radical Prostatectomy is still necessary
en
Prof. Hendrik van Poppel
What's new in stone treatment
en
Dr. Jens J. Rassweiler
The future of prostate cancer diagnosis
en
Prof. Mark Emberton
Bladder cancer and urinary diversion
en
Prof. Urs E. Studer
Robotic surgery: kidney cancer treatment
en
Dr. Alexandre Mottrie
The European Robotic Urology Society
en
Dr. Alexandre Mottrie
Focus on the Andrology session
en
Prof. Jens Sonksen
Penile preservation
en
Prof. Jens Sonksen
Prostate cancer: treatments & complications
en
Prof. Markus Graefen
Martini Klinik: a Centre of Excellence
en
Prof. Markus Graefen
Interstitial cystitis
it
Prof. Mauro Cervigni
Prostate cancer: patient management
it
Dr. Alberto Bossi
Prostate cancer in China
en
Dr. Ying-Hao Sun
Urethral reconstruction today
en
Dr. Luis Martinez-Pineiro Lorenzo